triamterene trade name dyrenium among others potassiumsparing diuretic often used combination thiazide diuretics treatment high blood pressure swelling combination hydrochlorothiazide known hydrochlorothiazidetriamterene common side effects may include depletion sodium folic acid calcium nausea vomiting diarrhea headache dizziness fatigue dry mouth serious side effects may include heart palpitations tinglingnumbness fever chills sore throat rash back pain triamterene also cause kidney stones direct crystallization seeding calcium oxalate stones triamterene best avoided patients chronic kidney disease due possibility hyperkalemia people using drug use salt substitute triamterene may impart blue fluorescent color urine diabetes use caution people prediabetes diabetes mellitus may change glucose control liver impairment use caution people severe liver dysfunction cirrhosis avoid electrolyte acidbase imbalances might lead hepatic encephalopathy kidney failure combined triamterene indomethacin therapy caused reversible acute kidney injury kidney stones use caution people kidney stones use avoided creatinine clearance less mlminute triamterene directly blocks epithelial sodium enac lumen side kidney collecting diuretics cause decrease sodium concentration forming urine due entry sodium cell via enac concomitant exit potassium principal cell forming urine blocking enac prevents happening amiloride works way sodium channel blockers directly inhibit entry sodium sodium channels triamterene commonly prepared combination hydrochlorothiazide treatment hypertension high blood pressure edema water retention combination class medications called diuretics water pills causes kidneys get rid bodys unneeded water sodium triamterene ring system found many naturally occurring compounds folic acid riboflavin observation naturally occurring compound xanthopterin renal affects led scientists smith kline french laboratories philadelphia begin medicinal chemistry campaign discover potential drugs part program discover potassiumsparing first clinical studies published first trials combining hydrochlorothiazide published next smith kline french launched single agent brand dyrenium combination drug hydrochlorothiazide dyazide first approved us first generic brought bolar pharmaceutical co approved dyazide prescribed drug us million sales making smithkline beckmans secondbiggest seller behind patents expired dyazide complications arose introductions generics formulation dyazide resulted variable batches made impossible generic manufacturers show versions bolar pharmaceutical running first bring generic application delayed concerns whether formulation provided amount drug complicated accusations bolar fraudulently substituted dyazide version conduct studies submitted shortly bolars generic approved concerns raised regard bolars applications market generics generally findings among others raised widespread concern among doctors public whether generics really branded bolar ended recalling generic form dyazide withdrawing product us justice department behalf fda filed criminal charges bolar early next year bolar pled guilty agreed pay public concern safety generic drugs exacerbated congressional investigation bribery fda generics companies found pervasive corruption investigation spurred generics company mylan hired private investigators based beliefs competitors getting unfair advantages getting generics mylan developed version triamterenehydrochlorothiazide combination drug dyazide patent expired used different stable well different dosages active ingredient mg hydrochlorothiazide mg triamterene compared dyazides mg hydrochlorothiazide mg triamterene get approval new drug opposed generic product called maxzide approved higher dose allowed per day dosing mylan marketing partner lederle believed would help compete dyazide sales mylans patents drug declared invalid court marketing exclusivity expired prompting rush generic competition litigation two american therapeutics inc vitarine pharmaceuticals vitarine along par pharmaceutical two companies mylan targeted investigation corruption turned par vitarine used mylans maxzide obtain bioequivalence data leading companies withdraw generic competitor mylans generics eventually entered lack randomized controlled trials evaluating use triamterene treatment ménières disease typical treatment mg triamterene mg hydrochlorothiazide capsules recommendation given strength recommendation taxonomy sort grade ccitation needed httpsenwikipediaorgwikitriamterene